Jpmorgan Chase & CO Inogen Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INGN
# of Institutions
143Shares Held
21MCall Options Held
119KPut Options Held
149K-
Camber Capital Management LP Boston, MA2MShares$17 Million0.62% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$13.8 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.56MShares$13.2 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$12.7 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.06MShares$8.96 Million1.38% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $194M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...